Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2026-02-27 @ 11:59 PM
Study NCT ID:
NCT02715193
Status:
COMPLETED
Last Update Posted:
2017-02-07
First Post:
2016-02-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus
Sponsor:
REMD Biotherapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-29
First Submit QC Date:
None
Study First Post Date:
2016-03-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-06
Last Update Post Date:
2017-02-07
Last Update Post Date Type:
ESTIMATED